Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pollard

Showing results (281-290 of 318) with videos related to

Pageof 32
Sort By:
Leukemia|April 12, 2014
Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemiaR B Walter, G S Laszlo, J M Lionberger, et al.
Blood|March 2, 2012
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AMLJessica A Pollard, Todd A Alonzo, Michael Loken, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 4, 2011
Location of biomarkers and reagents within agarose beads of a programmable bio-nano-chipJesse V Jokerst, Jie Chou, James P Camp, et al.
Journal of Lipid Research|January 7, 2015
HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of functionStela Z Berisha, Greg Brubaker, Takhar Kasumov, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Germline Variant Burden Warrants Universal Genetic Testing in Pediatric Myeloid LeukemiaLauren M Harmon, Zachary S Hattig, Yizhou Peter Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric <i>KMT2A</i>-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531Jessica A Pollard, Erin Guest, Todd A Alonzo, et al.
Annals of Translational Medicine|February 11, 2021
A comparison of the inflammatory response following autologous compared with allogenic islet cell transplantationWen Yuan Chung, Cristina A Pollard, Rohan Kumar, et al.
Pancreas|September 26, 2008
Islet auto transplantation following total pancreatectomy: a long-term assessment of graft functionM'Balu A Webb, Severine C Illouz, Cristina A Pollard, et al.
Transplantation and Cellular Therapy|June 18, 2022
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular TherapyKatherine Tarlock, Maria Luisa Sulis, Joseph H Chewning, et al.
Blood|April 24, 2010
Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupPhoenix A Ho, Rong Zeng, Todd A Alonzo, et al.
Pageof 32

Showing results (281-290 of 318) with videos related to

Sort By:
Pageof 32
Leukemia|April 12, 2014
Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemiaR B Walter, G S Laszlo, J M Lionberger, et al.
Blood|March 2, 2012
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AMLJessica A Pollard, Todd A Alonzo, Michael Loken, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 4, 2011
Location of biomarkers and reagents within agarose beads of a programmable bio-nano-chipJesse V Jokerst, Jie Chou, James P Camp, et al.
Journal of Lipid Research|January 7, 2015
HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of functionStela Z Berisha, Greg Brubaker, Takhar Kasumov, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Germline Variant Burden Warrants Universal Genetic Testing in Pediatric Myeloid LeukemiaLauren M Harmon, Zachary S Hattig, Yizhou Peter Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric <i>KMT2A</i>-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531Jessica A Pollard, Erin Guest, Todd A Alonzo, et al.
Annals of Translational Medicine|February 11, 2021
A comparison of the inflammatory response following autologous compared with allogenic islet cell transplantationWen Yuan Chung, Cristina A Pollard, Rohan Kumar, et al.
Pancreas|September 26, 2008
Islet auto transplantation following total pancreatectomy: a long-term assessment of graft functionM'Balu A Webb, Severine C Illouz, Cristina A Pollard, et al.
Transplantation and Cellular Therapy|June 18, 2022
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular TherapyKatherine Tarlock, Maria Luisa Sulis, Joseph H Chewning, et al.
Blood|April 24, 2010
Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupPhoenix A Ho, Rong Zeng, Todd A Alonzo, et al.
Pageof 32